Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics
© Amin et al. 2005
Received: 09 February 2005
Accepted: 22 September 2005
Published: 22 September 2005
Laminins are a group of proteins largely responsible for the anchorage of cells to basement membranes. We hypothesized that altered Laminin chain production in the bronchial mucosa might explain the phenomenon of epithelial cell shedding in asthma. The aim was to characterize the presence of Laminin chains in the SEBM and epithelium in allergic and non-allergic asthmatics.
Patients and methods
Biopsies were taken from the bronchi of 11 patients with allergic and 9 patients with non-allergic asthma and from 7 controls and stained with antibodies against the Laminin (ln) chains alpha1-alpha5, beta1-beta2 and gamma1-gamma2.
Lns-2,-5 and -10 were the main Laminins of SEBM. The layer of ln-10 was thicker in the two asthmatic groups while an increased thickness of lns-2 and -5 was only seen in allergic asthmatics. The ln gamma2-chain, which is only found in ln 5, was exclusively expressed in epithelial cells in association with epithelial injury and in the columnar epithelium of allergic asthmatics.
The uncoordinated production of chains of ln-5 in allergic asthma could have a bearing on the poor epithelial cell anchorage in these patients.
Asthma is a chronic inflammatory disease of the lungs that may have allergic or non-allergic causes [1–3]. The allergic type of asthma is characterized by the accumulation of eosinophils, mast cells and lymphocytes of the Th2-type in the bronchial mucosa, whereas the non-allergic asthma has a substantial accumulation of neutrophils in addition to eosinophils and mast cells . Structural changes and remodelling of the bronchial mucosa with signs of epithelial injury, subepithelial basement thickening, smooth muscle hypertrophy, increased vascularization and innervation are prominent features of the allergic type of asthma and less prominent in the non-allergic type .
Basement membranes (BMs) are built of cell-polymerizing networks of type IV collagens and laminins connected by nidogen/entactin [4, 5]. The major role of laminin for epithelial cells is to anchor them to BM for cell differentiation and maintenance of cell function. Laminins are heterotrimeric molecules made up by one α, one β and one γ chain. Until today we know of five α-chains, three β-chains and three γ-chains. These chains combine into at least 14 different Laminins (lns) i.e. lns 1–14. The distribution of these Laminin isoforms varies between tissues, but in most BMs more than one Laminin is present. The chains of laminins have different regions that function by binding to cellular receptor molecules among which the most abundant are integrins, dystroglycan and the recently characterized Lutheran blood group antigen [4, 6]. Several studies have shown the fundamental importance of intact Laminins in the BMs, since mutations may give rise to serious diseases such as epidermolysis bullosa in which the anchoring of the skin is grossly impaired . Laminins also interact with many other cells and promote migration and angiogenesis and their functions in tumour invasion is one of the hot research topics of today .
The injury of the respiratory epithelium in the bronchi in allergic asthmatics may be one of the mechanisms underlying bronchial hyperresponsiveness which is one of the main features of asthma [8–11]. The mechanisms behind the fragility of the epithelium in allergic asthmatics, i.e. the propensity of the epithelium to shed from its anchorage to the subepithelial basement membrane (SEBM) and basal cells have not been explained. Since one obligatory component in this anchoring process is mediated by Laminins, we hypothesized that uncoordinated production of Laminin chains might contribute to weaken these anchoring forces. Our aim was therefore to describe the presence of the various Laminins in the epithelium and especially SEBM of allergic asthmatics in comparison with non-allergic asthmatics and healthy non-asthmatic controls.
Materials and methods
Patient characteristics (n or median (range))
Healthy control (n = 7)
Allergic asthma (n = 11)
Non-allergic asthma (n = 9)
FEV1 (% pred)
FVC (% pred)
Symptom score *
All but one allergic and one non-allergic patient with asthma were on regular treatment with inhaled glucocorticosteroids (budesonide 200–800 g/day) and inhaled β2-agonists as needed. The average use of inhaled glucocorticosteroids was similar in the two asthma groups. A more detailed description of the study population has been presented in a previous report.
The patients were given 10 mg diazepam (Stesolid®, Dumex, Copenhagen, Denmark) orally and 0.5 mg atropine (Atropin, NM Pharma, Stockholm, Sweden) subcutaneously 30 minutes before the investigation. The upper airways were anaesthetized with lidocain hydrochloride (Xylocain, Astra, Södertälje, Sweden). Using a flexible fibre bronchoscope (Olympus P 20D) with a FB 15C 2,0 mm forceps (Olympus), two biopsies were taken from each of three different airway levels in the right lung: (A) in the upper lobe bronchus immediately after the division from the main bronchus, (B) at the division between the middle and lover lobe bronchi and (C) from the main lower lobe divisions. The specimens were immediately examined under a light microscope to ensure the presence of a complete mucosa and fixed as described below. The patients were instructed to take their regular asthma sprays the morning of the bronchoscopy.
The study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee at the Faculty of Medicine at the University of Uppsala.
The expression of different Laminin chains in the epithelium and in the subepithelial basement membrane was studied in frozen sections by the use of monoclonal antibodies and the alkaline phosphate-anti-alkaline phosphatase method (APAAP) visualization system. Mouse monoclonal antibodies (MAbs) against the ln α1 chain (clone 161 EB7), ln α4 chain (clone 168FC10), ln α5 (clone 4C7) [14, 15], ln β1 chain (clone 114DG.), ln β2 chain (clone C4, obtained from the hybridoma C4 developed by Joshua Sanes obtained from the Developmental Studies hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242), ln γ1 chain (113BC7), ln γ2 chain (clone D4B5)  were produced and characterized as described earlier. MAb against lns α2 and α3 chains (clones Lam M and P3H9-2, respectively) were purchased from Chemicon International, Temecula, California, USA.
The bronchial biopsy specimens were taken from the upper lobe and frozen immediately in melting propane previously cooled in liquid nitrogen and further processed as described in detail previously . Incubation with antibodies to ln α1 chain (diluted 1:4 in PBS), ln α2 chain (diluted 1:500 in PBS), ln α3 chain (diluted 1:1000 in PBS) ln α4 chain (diluted 1:5 in PBS), ln α5 (diluted 1:300 in PBS), ln β1 chain (diluted 1:400 in PBS), ln β2 chain (diluted 1:750 in PBS), ln γ1 chain (diluted 1:400 in PBS) and ln γ2 chain (diluted 1:1000 in PBS) were performed at room temperature in a humid chamber for 20 h and terminated by two rinses in PBS. The bound antibodies were visualized with the alkaline phosphates-anti-alkaline phosphatase method (APAAP kit K670, Dakocytomation, Glostrup, Denmark) using fast red substrate. The sections were counterstained with Mayer's hematoxylin (Merck; Darmstadt, Germany) for two minutes and mounted with Faramount (S 3025, Dako). In the negative controls, the primary antibodies were omitted.
Microscopic Evaluation of Sections
The Leica DMLB microscope (Wetzlar GmbH, Germany) was equipped with a Leica Microsystems digital camera (DC 300F) connected to a PC-computer. The images were captured and saved in the computer for further evaluation using the software package Qwin v2.7. In each biopsy two subsequent sections were evaluated. The thickness of the Laminin layers (in μm) was measured in immunolabeled frozen sections using a X10 objective and the computerized image analysis system after calibration with the aid of a stage micrometer. Measurements were carried out on 100 randomly selected sites per section and the results expressed as the mean of these measurements. The variation in estimation of structural changes between the two microscopic sections varied between 4–8% (% coefficient of variation). All slides were assessed by an observer blinded to the diagnosis of the patient.
All statistics were calculated using non-parametric tests. Comparisons between the three groups were initially performed by means of analysis of variance (Kruskal-Wallis test). In case of significance paired group comparisons were performed with the Mann-Whitney U-test. A p-value of <0.05 was regarded as statistically significant.
The thickness of various laminin chains in SEBM (μm)
Patchy, weak staining
2.83 (2.50–3.30)**, ‡‡‡
3.77 (3.30–4.40)***, ‡‡‡
4.10 (3.30–4.60)***, ‡‡‡
2.86 (2.40–3.50) **
4.84 (4.10–5.50)***, ‡‡‡
3.29 (3.10–3.80) ***
2.34 (2.10–2.800)*, ‡‡
4.86 (4.20–5.40) ***, ‡‡‡
3.49 (2.90–3.90) ***
2.96 (2.60–3.50)**, ‡‡‡
Ln β1-chains were seen in the SEBM and the thickness was significantly higher in biopsies from allergic asthmatics as compared to non-allergics and healthy controls (Table 2). The staining of SEBM with antibodies against the β2-chain showed a slight increase of the thickness in allergic asthmatics as compared to non-allergic asthmatics and controls, but with no difference between non-allergic asthmatics and controls (Table 2).
When combining the information on individual laminin chains, we found that lns-2 (α2β1γ1),-5 (α3β3γ2) and -10 (α5β1γ1) were the main laminins of the SEBM. The layer of ln-10 was thicker in the two asthmatic groups while an increased thickness of lns-2 and -5 was only seen in allergic asthmatics. The staining of ln γ2-chain in the absence of ln α3 in epithelial cells does not fit with any presently known laminin.
This study has systematically investigated the presence of most Laminin chains in the epithelium and SEBM of both allergic and non-allergic asthmatics. The primary object was to test the hypothesis that differences in Laminin chain compositions in SEBM might help explain the phenomenon of epithelial fragility and shedding as is typically seen in biopsies of allergic asthmatics . We found several alterations in the Laminin chain composition in the SEBM of allergic asthmatics. Most of these differences seemed quantitative rather than qualitative. Unexpectedly we found distinct qualitative differences with respect to ln-5 chain compositions that may have a bearing on the poorer anchorage of epithelial cells to BM in allergic asthma. The finding of a close correlation between ln γ2-chain deposition and epithelial injury indeed emphasises the close relationship between laminin chain production and epithelial injury as is observed in certain subjects with asthma. However, the relationship does not tell us whether epithelial shedding is a cause of the uncoordinated laminin chain production or whether the uncoordinated production is a consequence of the repair processes induced by epithelial injury.
The unexpected findings were both related to the ln γ2-chain staining. According to the present knowledge the γ2-chain is only found as part of ln-5 (α3β3γ2) [4, 18]. In our biopsies we found exclusive staining with the antibodies against the γ2-chain in the epithelium, with no sign of simultaneous staining with antibodies against the α3-chain. The epithelium staining could be a reflection of the fact that airways epithelium is a producer of the ln γ2-chain and that the staining reflects the deposition of non-secreted protein. It was of particular interest that we found accumulation of immunoreactivity in the apical part of intact columnar epithelium in allergic asthmatics, but not in the other two groups, whereas staining of the basal cells were seen in all three groups in areas of epithelial destruction. This staining was observed without any concomitant staining of the complementary ln-5 α3 chain, which suggests an uncoordinated production of the γ2 chain in the epithelium of allergic asthmatics resulting in the intracellular accumulation of the γ2 chain, since the extracellular secretion probably requires the assembly of the heterotrimeric molecule . The staining pattern could also indicate the presence of a hitherto unrecognised Laminin or alternatively that the α3 chain had been proteolytically modified with the loss of the particular epitope recognized by our monoclonal antibodies .
The intense staining of the cytoplasm of basal cells in areas of epithelial injury suggests that the basal cells are producers of the ln γ2 chain and probably also of the whole heterotrimeric complex of ln-5, although no staining of the other two chains was observed. Indeed, sole expression of ln γ2 chain has been shown in invading tumour cells[4, 20], which shows that uncoordinated production of the three ln-5 chains may take place under certain conditions. It is also of interest that Lappi-Blanco et al. in a recent report found ln γ2 chain expression to be increased in regenerating epithelial cells and also found γ2 chain in basal cells of normal bronchus . These results suggest that our findings of intense staining seen in the basal cells at areas of tissue injury may be a sign of re-epithelialization and repair.
The SEBM showed the presence of mainly three Laminins i.e. ln-5 (α3β3γ2), ln-10 (α5β1γ1) and ln-2 (α2β1γ1). The two former were expected based on earlier findings [4, 22], whereas the presence of ln-2 mostly is associated with BMs surrounding tissues such as muscles and nerves . In a previous report we indicated the wide presence of α1-chains in SEBM, which is seemingly contrasted by the present results. Those results, however, were based on the false assumption that the monoclonal antibody 4C7 specifically recognizes α1-chains, which is not the case. The 4C7 antibody only recognizes the α5-chains [14, 15]. As was previously found the thickness of the Laminin layer in the SEBM was increased in allergic asthmatics as compared to both non-allergic asthmatics or healthy controls . This difference was most obvious for ln-10, since also the thickness found in non-allergic asthmatics was increased as compared to healthy non-asthmatic controls. This was contrasted by the increased thickness of ln-5 and -2, which was only seen in allergic asthmatics. These differences, therefore suggest qualitative differences in the production of various chains in allergic and non-allergic asthmatics, which may relate to the differences in the inflammatory processes going on in these two diseases. The allergic asthma being eosinophil-mast cell-Th2 driven and the non-allergic asthma being more neutrophil-mast cell driven, although eosinophils are also present at increased amounts in the non-allergic asthma .
As mentioned above the primary aim of this work was to test the hypothesis that an imbalance in Laminin chain production might explain the observed epithelial cell loss in allergic asthmatics. This hypothesis is seemingly refuted by our data, since others have shown that ln-5 induces the formation of hemidesmosomes , which actually promote stable cell:matrix adhesion. Another interesting property of ln-5 is the biological activity of the proteolytically modified fragments, which might modify cellular behaviours . However, it should also be noted that mutations or modifications of any of the chains of ln-5 are associated with severe disease due to separation of epithelia from the underlying basement membrane . Thus, we cannot exclude any processing of ln-5 in the inflamed tissue of allergic asthma as an explanation of poor anchorage of the epithelial cells in the bronchi to the underlying basement membrane.
We conclude that Laminin chain deposition in the epithelium and SEBM of allergic and non-allergic asthmatics differs in qualitative and quantitative terms and that there is a close relationship between ln γ2-chain deposition and epithelial injury. The uncoordinated production of the chains of ln-5 in the epithelium of allergic asthmatics may be of particular interest, since ln-5 promotes the formation of hemidesmosomes, which promote stable cell matrix adhesion.
alkaline phosphate-anti-alkaline phosphatase
Mouse monoclonal antibodies
subepithelial basement membrane
The participation of members of the BHR-group is appreciated.
This study was supported by grants from the Swedish Heart and Lung Foundation, the Care and Allergy Foundation (Vårdalstiftelsen) and the Swedish Allergy and Asthma Foundation.
- Holgate ST: The epidemic of allergy and asthma. Nature 1999, 402:B2-B4.View ArticlePubMedGoogle Scholar
- Busse WW, Rosenwasser LJ: Mechanisms of asthma. J Allergy Clin Immunol 2003, 111:S799-S804.View ArticlePubMedGoogle Scholar
- Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Bjornsson E, Roomans GM, Boman G, Seveus L, Venge P: Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. Am J Respir Crit Care Med 2000, 162:2295–2301.View ArticlePubMedGoogle Scholar
- Patarroyo M, Tryggvason K, Virtanen I: Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol 2002, 12:197–207.View ArticlePubMedGoogle Scholar
- Libby RT, Champliaud MF, Claudepierre T, Xu Y, Gibbons EP, Koch M, Burgeson RE, Hunter DD, Brunken WJ: Laminin expression in adult and developing retinae: evidence of two novel CNS laminins. J Neurosci 2000, 20:6517–6528.PubMedPubMed CentralGoogle Scholar
- Kikkawa Y, Moulson CL, Virtanen I, Miner JH: Identification of the binding site for the Lutheran blood group glycoprotein on laminin alpha 5 through expression of chimeric laminin chains in vivo. J Biol Chem 2002, 277:44864–44869.View ArticlePubMedGoogle Scholar
- McGowan KA, Marinkovich MP: Laminins and human disease. Microsc Res Tech 2000, 51:262–279.View ArticlePubMedGoogle Scholar
- Fireman P: Understanding asthma pathophysiology. Allergy Asthma Proc 2003, 24:79–83.PubMedGoogle Scholar
- Ludviksdottir D, Janson C, Bjornsson E, Stalenheim G, Boman G, Hedenstrom H, Venge P, Gudbjornsson B, Valtysdottir S: Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjogren's syndrome. BHR Study Group. Bronchial hyperresponsiveness. Allergy 2000, 55:259–265.View ArticlePubMedGoogle Scholar
- Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V: Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998, 157:4–9.View ArticlePubMedGoogle Scholar
- Kushima A, Motojima S, Yamai T, Makino S: The participation of epithelial desquamation in the increase of bronchial hyperresponsiveness after antigen challenge in patients with bronchial asthma. Allergy (Japan) 1990, 39 No.12:1581–1589.Google Scholar
- Virtanen I, Gullberg D, Rissanen J, Kivilaakso E, Kiviluoto T, Laitinen LA, Lehto VP, Ekblom P: Laminin alpha1-chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues. Exp Cell Res 2000, 257:298–309.View ArticlePubMedGoogle Scholar
- Petajaniemi N, Korhonen M, Kortesmaa J, Tryggvason K, Sekiguchi K, Fujiwara H, Sorokin L, Thornell LE, Wondimu Z, Assefa D, Patarroyo M, Virtanen I: Localization of laminin alpha4-chain in developing and adult human tissues. J Histochem Cytochem 2002, 50:1113–1130.View ArticlePubMedGoogle Scholar
- Engvall E, Earwicker D, Haaparanta T, Ruoslahti E, Sanes JR: Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul 1990, 1:731–740.PubMedPubMed CentralGoogle Scholar
- Tiger CF, Champliaud MF, Pedrosa-Domellof F, Thornell LE, Ekblom P, Gullberg D: Presence of laminin alpha5 chain and lack of laminin alpha1 chain during human muscle development and in muscular dystrophies. J Biol Chem 1997, 272:28590–28595.View ArticlePubMedGoogle Scholar
- Virtanen I, Lohi J, Tani T, Korhonen M, Burgeson RE, Lehto VP, Leivo I: Distinct changes in the laminin composition of basement membranes in human seminiferous tubules during development and degeneration. Am J Pathol 1997, 150:1421–1431.PubMedPubMed CentralGoogle Scholar
- Mizushima H, Koshikawa N, Moriyama K, Takamura H, Nagashima Y, Hirahara F, Miyazaki K: Wide distribution of laminin-5 gamma 2 chain in basement membranes of various human tissues. Horm Res 1998, 50 Suppl 2:7–14.PubMedGoogle Scholar
- Tunggal P, Smyth N, Paulsson M, Ott MC: Laminins: structure and genetic regulation. Microsc Res Tech 2000, 51:214–227.View ArticlePubMedGoogle Scholar
- Hintermann E, Quaranta V: Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors. Matrix Biol 2004, 23:75–85.View ArticlePubMedGoogle Scholar
- Katayama M, Sekiguchi K: Laminin-5 in epithelial tumour invasion. J Mol Histol 2004, 35:277–286.View ArticlePubMedGoogle Scholar
- Lappi-Blanco E, Kaarteenaho-Wiik R, Salo S, Sormunen R, Maatta M, Autio-Harmainen H, Soini Y, Paakko P: Laminin-5 gamma2 chain in cryptogenic organizing pneumonia and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004, 169:27–33.View ArticlePubMedGoogle Scholar
- Virtanen I, Laitinen A, Tani T, Paakko P, Laitinen LA, Burgeson RE, Lehto VP: Differential expression of laminins and their integrin receptors in developing and adult human lung. Am J Respir Cell Mol Biol 1996, 15:184–196.View ArticlePubMedGoogle Scholar
- Patton BL: Laminins of the neuromuscular system. Microsc Res Tech 2000, 51:247–261.View ArticlePubMedGoogle Scholar
- Altraja A, Laitinen A, Virtanen I, Kämpe M, Simonsson BG, Karlsson SE, Håkansson L, Venge P, Sillastu H, Laitinen LA: Expression of laminins in the airways in various types of asthmatic patients: A morphometric study. Am J Respir Cell Mol Biol 1996, 15:482–488.View ArticlePubMedGoogle Scholar
- Michelson PH, Tigue M, Jones JC: Human bronchial epithelial cells secrete laminin 5, express hemidesmosomal proteins, and assemble hemidesmosomes. J Histochem Cytochem 2000, 48:535–544.View ArticlePubMedGoogle Scholar
- Ghosh S, Stack MS: Proteolytic modification of laminins: functional consequences. Microsc Res Tech 2000, 51:238–246.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.